• Call Us 017250 47439

Ensures Comfortable Breathing

  • Acebrophylline has been found to improve ciliary clearance, reduce the frequency of episodes of bronchial obstruction, reduce the need for β2- agonists and improve indices of ventilatory function.
  • Acebrophylline has early and positive effect on the quantity and viscosity of expectoration and marked improvement symptoms of patients, with favourable changes in respiratory function.
  • NAC is used in wide range of respiratory diseases due to its mucolytic and anti-oxidant activities, making it attractive as a potential chronic obstructive pulmonary disease therapy.
  • NAC therapy is a safe and effective modality that may reduce the decline in the lung function of patients with Idiopathic Pulmonary Fibrosis.

Effective In :-

Acute and Chronic Bronchitis
Chronic Obstructive Pulmonary Disease
Sinusitis and Rhinitis
Pulmonary Complications of Cystic Fibrosis
Bronchial Asthma
Chronic Emphysema
Bronchial Hyperresponsiveness
Atelectasis due to Mucus Obstruction